
August 2026, Vol 317, No 8012
Top news stories


Updated hypertension case‑finding service draws calls for impact assessment

New pharmacy minister confirmed

MHRA approves orforglipron weight-loss pill

Pharma companies reported fewer medicine supply issues in 2026

Government did not conduct impact assessment for community pharmacy prescribing

Once-weekly HIV pill performs as well as daily treatment in phase III study
Features

Next frontier: crystallising the future of medicines

Spotlight: The battle for EPS nominations

What causes medicines shortages: the supply chain explained

A faster route to rare disease treatments: the MHRA’s proposals

How climate change is reshaping the UK’s risk of vector-borne diseases
Opinion

Training to spot microaggressions should be mandatory in pharmacy foundation education

PJ view: Pharmacy must be central to Burnham’s plan to tackle regional health inequalities

Improving access to medicines for patients with reduced hand function

From liquids to solids: resetting paediatric prescribing for a safer, sustainable future

Moving from conversation to action on women’s health

Alex Williams: ‘There’s a risk to the resilience of the supply chain if government doesn’t invest’

A unique role in the community: supporting social care and discharge services as a pharmacy technician

What increasing impact factors mean for the RCPharm research journals

How pharmacists can transform prescribing safety in psychiatry

Virtual reality holds the promise of filling medicines manufacturing workforce gaps
Learning & CPD

Assessing authorship, study purpose and journals when evaluating clinical studies

Case-based learning: optimising falls prevention through a multidisciplinary approach

Identifying and evaluating research study types

A model for successful credentialing in pharmacy

Test your knowledge of medicines safety

Writing an effective CV for pharmacy roles: a guide for graduates

Best practice for prescribing drugs with dependence potential
Royal College of Pharmacy news

Urgent action on Scotland’s healthy life expectancy gap needed, RCPharm conference told
